Mengting Li

1.5k total citations
62 papers, 1.1k citations indexed

About

Mengting Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mengting Li has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Mengting Li's work include Nanoplatforms for cancer theranostics (7 papers), Peptidase Inhibition and Analysis (7 papers) and RNA modifications and cancer (6 papers). Mengting Li is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Peptidase Inhibition and Analysis (7 papers) and RNA modifications and cancer (6 papers). Mengting Li collaborates with scholars based in China, United States and Iran. Mengting Li's co-authors include Xiaoli Lan, Weibo Cai, Ross Crawford, Fei Wei, Yinghong Zhou, Yin Xiao, Yongxue Zhang, Yongkang Gai, Hongyu Ji and Nannan Zheng and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and Scientific Reports.

In The Last Decade

Mengting Li

57 papers receiving 1.1k citations

Peers

Mengting Li
Comparison fields: 5 of 127
  • Molecular Biology 428
  • Biomedical Engineering 319
  • Oncology 168
  • Materials Chemistry 159
  • Cancer Research 143
Replace Meng Jia with:
Meng Jia China
Chenyang Zhao China
Zhuo Georgia Chen United States
Yi‐Jang Lee Taiwan
Neha Aggarwal India
Sang Kyoon Kim South Korea
Kai‐Wen Huang Taiwan
Yawen Guo China
Maya Nair United States
Arianna Bonizzi Italy
Meng Jia China View profile →
Citations per field, relative to Mengting Li
Mengting Li · 1×
Citations per year, relative to Mengting Li
Mengting Li · 1×

Countries citing papers authored by Mengting Li

Since Specialization
Citations

This map shows the geographic impact of Mengting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengting Li more than expected).

Fields of papers citing papers by Mengting Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengting Li. The network helps show where Mengting Li may publish in the future.

Co-authorship network of co-authors of Mengting Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengting Li. A scholar is included among the top collaborators of Mengting Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengting Li. Mengting Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 5
4 3
5 3
6 5
7 7
8 4
9 1
10 15
11 42
12 79
13 16
14 7
15 144
16 13
17 1
18 11
19 13
20 15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026